Immediate Impact
2 from Science/Nature 59 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Works of Lan Shen being referenced
1377P Preliminary efficacy and safety results of KN026 (a HER2-targeted bispecific antibody) in combination with KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in patients (pts) with HER2-positive gastrointestinal tumors
2021
Low Serum miR‐607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lan Shen | 73 | 126 | 70 | 80 | 40 | 393 | |
| Lei Zhou | 45 | 139 | 60 | 67 | 33 | 432 | |
| Yan Liu | 60 | 107 | 52 | 73 | 22 | 368 | |
| Asako Kumagai | 63 | 161 | 92 | 61 | 25 | 414 | |
| Wei Meng | 64 | 194 | 62 | 101 | 46 | 427 | |
| Xiucheng Liu | 40 | 176 | 68 | 69 | 38 | 431 | |
| Zhipeng Wen | 41 | 154 | 25 | 103 | 33 | 409 | |
| Rui Wang | 118 | 81 | 82 | 69 | 47 | 336 | |
| Benling Qi | 83 | 143 | 81 | 43 | 35 | 419 | |
| Xiaobo Ma | 25 | 108 | 85 | 64 | 49 | 396 | |
| Kazuyuki Koike | 97 | 165 | 44 | 66 | 26 | 385 |
All Works
Login with ORCID to disown or claim papers
Loading papers...